Evaluation of Radiolabeled Type IV Collagen Fragments as Potential Tumor Imaging Agents-Reference-Cited by-同舟云学术

Evaluation of Radiolabeled Type IV Collagen Fragments as Potential Tumor Imaging Agents

Published:2001-10-20 Issue:6 Volume:12 Page:1057-1065
ISSN:1043-1802
Container-title:Bioconjugate Chemistry
language:en
Short-container-title:Bioconjugate Chem.

Author:

Edwards W. Barry¹,Anderson Carolyn J.¹,Fields Gregg B.¹,Welch Michael J.¹

Affiliation:

1. Mallinckrodt Institute of Radiology, Washington University School of Medicine, St. Louis, Missouri 63110 and Department of Chemistry and Biochemistry, Florida Atlantic University, Boca Raton, Florida 33431

Publisher

American Chemical Society (ACS)

Subject

Organic Chemistry,Pharmaceutical Science,Pharmacology,Biomedical Engineering,Bioengineering,Biotechnology

Link

https://pubs.acs.org/doi/pdf/10.1021/bc015520d

Reference47 articles.

1. Utilization of metabolic, transport and receptor-mediated processes to deliver agents for cancer diagnosis

2. Radiometal-Labeled Agents (Non-Technetium) for Diagnostic Imaging

3. Somatostatin receptor scintigraphy with [111In-DTPA-d-Phe1]- and [123I-Tyr3]-octreotide: the Rotterdam experience with more than 1000 patients

4. The membrane glycoprotein Ia-IIa (VLA-2) complex mediates the Mg++-dependent adhesion of platelets to collagen.

Cited by 14 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Synthesis and Preclinical Evaluation of a 68Ga-Radiolabeled Peptide Targeting Very Late Antigen-3 for PET Imaging of Pancreatic Cancer;Molecular Pharmaceutics;2020-06-16

2. In vivo fate tracking of degradable nanoparticles for lung gene transfer using PET and Ĉerenkov imaging;Biomaterials;2016-08

3. A practical guide to the construction of radiometallated bioconjugates for positron emission tomography;Dalton Transactions;2011

4. Integrin Targeted Delivery of Radiotherapeutics;Theranostics;2011

5. Impact of Hydrogel Nanoparticle Size and Functionalization on In Vivo Behavior for Lung Imaging and Therapeutics;Molecular Pharmaceutics;2009-11-03